Compare

Outset Medical, Inc. vs Ceribell, Inc. vs Electromed, Inc. vs Axogen, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearOutset Medical, Inc.
OM
Ceribell, Inc.
CBLL
Electromed, Inc.
ELMD
Axogen, Inc.
AXGN
Year ended2025-12-312025-12-312026-06-302025-12-31
Revenue$119.48M$89.06M$73.78M$225.21M
Revenue growth (YoY)+5.1%+36.1%+15.3%+20.2%
Gross margin39.1%87.9%78.5%74.3%
Operating margin-55.8%-65.6%18.8%-3.5%
Net margin-68.3%-60.0%15.3%-7.0%
Net income-$81.65M-$53.41M$11.30M-$15.70M
EPS (Diluted)-$5.37-$1.46$1.30-$0.34
Operating cash flow-$46.33M-$40.81M$9.66M$812.0K
Free cash flow-$47.12M-$41.58M$8.41M-$2.93M
Cash & equivalents$35.01M$40.48M$20.45M$35.55M
Total assets$264.50M$195.80M$66.27M$221.69M
Total liabilities$137.54M$40.47M$12.29M$92.84M
Shareholders' equity$126.95M$155.34M$53.98M$128.85M
Return on year-end equity-64.3%-34.4%20.9%-12.2%
Shares outstanding18.17M37.49M8.37M47.20M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearOutset Medical, Inc.Ceribell, Inc.Electromed, Inc.Axogen, Inc.
Latest$119.48M
Ended 2025-12-31
$89.06M
Ended 2025-12-31
$73.78M
Ended 2026-06-30
$225.21M
Ended 2025-12-31
1 year earlier$113.69M
Ended 2024-12-31
$65.44M
Ended 2024-12-31
$64.00M
Ended 2025-06-30
$187.34M
Ended 2024-12-31
2 years earlier$130.38M
Ended 2023-12-31
$45.23M
Ended 2023-12-31
$54.72M
Ended 2024-06-30
$159.01M
Ended 2023-12-31
3 years earlier$115.38M
Ended 2022-12-31
n/a$48.07M
Ended 2023-06-30
$138.58M
Ended 2022-12-31
4 years earlier$102.60M
Ended 2021-12-31
n/a$41.66M
Ended 2022-06-30
$127.36M
Ended 2021-12-31